Alejandra Guerchicoff

Dr. Alejandra Guerchicoff is a PhD in molecular genetics with a post-doctoral training in molecular cardiology. She is working as an Industry Advisor for TCS ADD platform with the Life Sciences unit at Tata Consultancy Services (TCS). Dr. Guerchicoff possesses a rich experience of more than 20 years in the domain of clinical research and post-marketing pharmacovigilance, for medical devices, drugs, combination products, gene and cell therapy, and software as medical device products. She has authored many prestigious journal publications and books on diverse subjects and different therapeutic areas. In her current role, Dr. Alejandra Guerchicoff is working for the development of innovative technology solutions with use of artificial intelligence and other modern technologies across various life sciences operations.

Email ID: a.guerchicoff@tcs.com

Alejandra Guerchicoff's articles

Next-gen Medical Writing: The Current State and Future Perspective

White Paper | 10 Jul 2024

TCS at WDSC Americas 2023: Discussing Pharmacovigilance in the AI Era

Events | 29 Aug 2023

Transforming PV Efficiencies with ML and Rule-based Automation

White Paper | 18 Aug 2023

The new age digital contract research organizations

White Paper | 23 Dec 2022

TCS is here to make a difference through technology.

We deliver excellence and create value for customers and communities.

Extraordinary expertise leads to remarkable results.

Want to be a global change-maker? Join our team.

Find the latest news about TCS in our Newsroom

Recent Press releases

Recent News

Recent recognitions

Upcoming events

TCS works hand in hand with world-leading investors.

Global knowledge. Local support